NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
about
BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent mannerUnique aspects of transcriptional regulation in neurons - nuances in NFkappaB and Sp1-related factorsThe c-Rel transcription factor and B-cell proliferation: a deal with the devilCurcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stabilityGlucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.Classical swine fever virus NS2 protein promotes interleukin-8 expression and inhibits MG132-induced apoptosis.Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaBMeningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent mannerActivation of p73 and induction of Noxa by DNA damage requires NF-kappa B.Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cellsI-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.Activation of the mTOR signaling pathway in breast cancer MCF‑7 cells by a peptide derived from Porphyra yezoensis.IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic function.NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region.Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells.C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.Associations of NF-kappaB and bax with apoptosis in varicose veins of women of different age groups.The c-Rel Transcription Factor in Development and Disease.Eucommia ulmoides Oliv. (Du-Zhong) Lignans Inhibit Angiotensin II-Stimulated Proliferation by Affecting P21, P27, and Bax Expression in Rat Mesangial Cells.Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway.Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability.Physical and functional interaction between the ID1 and p65 for activation of NF-κBNFkappaB in neurons? The uncertainty principle in neurobiologyAKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory functionPathophysiological Significance of Hepatic ApoptosisDeconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.The role of bortezomib in the treatment of lymphoma.Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cellsBcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression in cystic fibrosis airways: role in oxidant-mediated cell deathThe i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern.DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6.The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.
P2860
Q24324399-3F6CA7D4-C24A-4617-8126-FF26D523DEBAQ27497836-8929D766-5654-4A40-86DC-A2467595A840Q28241767-331DE37D-08EE-4B6D-84F5-EE5BD84437C6Q28538024-F2DFF88C-13D8-47F0-808D-A5C00D059522Q28572231-5EF5E718-E12E-43E1-A877-D443D8A0DC5DQ33375800-0F1871F2-FEA6-455A-9886-4C78C1B391FAQ33394120-3C6D89BF-6285-4672-A280-314ED84B8EAAQ33402885-6EFB7BCB-B724-41D4-9A11-36CAF2784B06Q33613556-EA60A84A-A2A3-4BFA-975F-6276206EAF78Q33676065-D41EC859-B9C7-49E3-BAC0-AE3A01B13D88Q33694155-12AA8D88-4E66-4798-BBDA-AC41F5FF28C5Q33829152-394B884E-4F61-4E54-995D-CBDC2FA8D5B1Q33860585-1088586F-9A33-4AF5-9A12-9272D4D64D0EQ33878632-2063AD2A-289D-4FE9-A32A-CBEC8E240417Q33980966-48B6433B-390B-42C6-ADA9-75CB130B1FE0Q34133753-B606651B-B437-4140-A279-CC3901B60F81Q34454573-34687CBE-1166-4709-90B3-D89562989FD0Q34626081-41496446-8FC4-48E3-9BE5-4BCFB403BAC2Q34730816-6490CC8C-C054-424E-BB77-1B375325C4D4Q35130452-25E43BE8-5173-48A1-9BE9-8B95F84ACC62Q35131571-5D796488-6C39-4EFE-9D87-DD035592A078Q35387968-29E892F7-6D0C-4848-92E6-07EEA9CF5842Q35504282-54A41CA6-BF8F-46AB-AEED-690C25686FE5Q35556506-965319E3-566E-486D-B3E6-AC0E98E5CFA8Q35773316-4D862154-E7FF-4285-9B06-828B463567D3Q36057212-253A5D2D-0533-4CA3-8E40-A5E1C1FDC91AQ36059547-F1677767-E7BA-4533-B340-011D2A7CA700Q36175739-96D2AAD4-F639-4C19-B408-B09C9FF6F631Q36435841-91C85038-0F3C-40B3-B66E-CC9E73945AEBQ36670941-95DD0E68-454E-4A96-9C5F-CC1747893D70Q36681959-ECDA5238-5D61-4111-9EF1-202E21525D80Q36961965-E9E732D3-2C54-4FF1-AE82-F640C129AF2AQ36966230-05559C62-D4AF-449F-B8B2-41B4D23373EDQ37024073-FD7A1916-B105-4071-A592-2986B8B71254Q37037146-57A5E480-C4DF-4803-B999-DBACFC798AD2Q37175235-2FF6517C-7682-42E2-9653-29B4F8F3212AQ37455886-E49B6F5C-D4FD-41B7-8A5B-60B2BE2AE492Q37656349-586CE723-CDA4-4F7D-B946-19B08E2A3521Q37663382-18C9579B-0883-469E-97DC-FC6A21CAB910Q37729845-6C9A930E-BDC2-40EE-9D4B-5BB0F18B2612
P2860
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
@en
type
label
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
@en
prefLabel
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
@en
P2093
P356
P1433
P1476
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
@en
P2093
Caroline A Heckman
John W Mehew
Linda M Boxer
P2888
P304
P356
10.1038/SJ.ONC.1205483
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1050675426